Ernexa Therapeutics Inc. (ERNAW) Operating margin 2016–2025
Ernexa Therapeutics Inc. (ERNAW) operating margin by fiscal year — reported operating income divided by reported revenue.
-1601.2%FY2025 · since FY2016: -9.3% → -1601.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1601.2% | +21448.8 pp |
| FY2024 | -23050.0% | — |
| FY2021 | -1960.9% | -1924.3 pp |
| FY2020 | -36.6% | -29.0 pp |
| FY2019 | -7.6% | -8.5 pp |
| FY2018 | 1.0% | +7.2 pp |
| FY2017 | -6.3% | +3.0 pp |
| FY2016 | -9.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice